Brief: Crescita Therapeutics QTRLY Revenue Was $4.9 Million
Nov 7 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* CRESCITA THERAPEUTICS INC - QTRLY REVENUE WAS $4.9 MILLION
VERSUS $4.5 MILLION
Source text for Eikon: ID:nPn52QSq2a
Further company coverage: CTX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium